Life sciences briefing: Thursday, Nov. 8, 2007
Featured companies: Formac Pharmaceuticals, Pradama, Protein Sciences, SantoSolve, Scandius BioMedical
UPDATED: Expanded items on Protein Sciences, SantoSolve, Scandius and Pradama.
Vaccine maker Protein Sciences gets $1M — Protein Sciences, a Meriden, Conn., biotech working on a faster way to make flu vaccines, raised $1 million in a convertible-debt offering. Diamyd Medical, a Stockholm-based biotech focused on diabetes, provided the funding.
The funding boosts Diamyd’s total investment in Protein Sciences to $4 million. Conversion of its earlier investment made the Swedish… Continue Reading
Life sciences briefing: Tuesday, Sept. 25, 2007
Featured companies: Biolipox, Inflazyme, Upfront Chromatography, Vertebron00
[NOTE: This is a catchup daily briefing posted on 9/27/07. I've adjusted the posting's timestamp to maintain the chronological order of briefings. --D.P.H.]
Sweden’s Biolipox pays up to $11M for Inflazyme assets — Venture-backed Biolipox, a Swedish biotech focused on inflammatory disease, agreed to pay up to $11 million for the majority of assets controlled by Inflazyme Pharmaceuticals, a publicly traded biotech in British Columbia, Canada. Biolipox will pay $4 million up… Continue Reading
Tibco to buy business intelligence software co., Spotfire, for $195M
Tibco, a Palo Alto, Calif. software company, said it has agreed to buy business intelligence software company Spotfire, of Somerville, Mass. for about $195 million in cash.
Tibco said its own software, which gives companies a way to manage their data infrastructure in “real time,” would be complimented by Spotfire’s business intelligence offering. It is the latest in a string of acquisitions of business intelligence companies.
See the Tibco’s statement about the acquisition and other info pages… Continue Reading